Harbour Antibodies's competitors

Harbour Antibodies's competitors include Microskin, Esperite, NovellusDx and Potenza Therapeutics
Add company...
Harbour Antibodies
Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.
Microskin
The result of years of research is a world first revolutionary new Australian product called Microskin. Microskin will not rub off, is completely waterproof, allows the skin to breathe and sweat, and would last for several days.
Esperite
Cryo-Save is the largest family stem cell bank in Europe with over 225,000 samples stored in lab facilities in Europe, Asia and Africa.
NovellusDx
NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity
Founding Date
Founding Date
2006
Founding Date
2005
Founding Date
2000
Founding Date
2012
Founding Date
2014
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Wavell Heights, AU HQ
Locations
Zutphen, NL HQ
Locations
Jerusalem, IL HQ
Locations
Cambridge, US HQ
Employees
Employees
1
Employees
N/A
Employees
205
Employees
N/A
Employees
19
Valuation ($)
Valuation ($)
N/A
Valuation ($)
1 m
Valuation ($)
8.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Facebook likes
Facebook likes
N/A
Facebook likes
795
Facebook likes
846
Facebook likes
18
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
4.5 k
Twitter followers
574
Twitter followers
N/A
Twitter followers
50

Funding

Latest funding round
Latest funding round
$ 3.2m (almost 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 6m (24 days ago)
Latest funding round
$ 30m (about 2 years ago)
Total funding raised
Total funding raised
$ 3.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 34.5m
Total funding raised
$ 30m
For sources of this data, please see the company profileDownload Excel

View company profiles

Microskin
HQ
Wavell Heights, AU

The result of years of research is a world first revolutionary new Australian product called Microskin. Microskin will not rub off, is completely waterproof, allows the skin to breathe and sweat, and would last for several days.

View company
Esperite
HQ
Zutphen, NL
Employees
205

Cryo-Save is the largest family stem cell bank in Europe with over 225,000 samples stored in lab facilities in Europe, Asia and Africa.

View company
NovellusDx
HQ
Jerusalem, IL

NovellusDx is dedicated to delivering the actionable intelligence that oncologists require to choose the right therapy for each patient. NovellusDx provides comprehensive, fully-automated, functional gene profiling of individual patient tumors including charting the full landscape of known and unknown mutations that drive the cancer’s progression.

View company
Potenza Therapeutics
HQ
Cambridge, US
Employees
19

Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity

View company